Newsletter
Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

JAMA Editor’s Summary

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue
November 5, 2019

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
The Happy Nurse: Sustaining the Health of Nurses with Kay Reynoldson